Order Article Reprints

Umbarawan Y, Kawakami R, Syamsunarno MRAA, Obinata H, Yamaguchi A, Hanaoka H, Hishiki T, Hayakawa N, Koitabashi N, Sunaga H, et al. Reduced Fatty Acid Use from CD36 Deficiency Deteriorates Streptozotocin-Induced Diabetic Cardiomyopathy in Mice. Metabolites. 2021; 11(12):881. https://doi.org/10.3390/metabo11120881

Umbarawan, Yogi, Ryo Kawakami, Mas Rizky A. A. Syamsunarno, Hideru Obinata, Aiko Yamaguchi, Hirofumi Hanaoka, Takako Hishiki, Noriyo Hayakawa, Norimichi Koitabashi, Hiroaki Sunaga, and et al. 2021. "Reduced Fatty Acid Use from CD36 Deficiency Deteriorates Streptozotocin-Induced Diabetic Cardiomyopathy in Mice" Metabolites 11, no. 12: 881. https://doi.org/10.3390/metabo11120881

Umbarawan, Y., Kawakami, R., Syamsunarno, M. R. A. A., Obinata, H., Yamaguchi, A., Hanaoka, H., Hishiki, T., Hayakawa, N., Koitabashi, N., Sunaga, H., Matsui, H., Kurabayashi, M., & Iso, T. (2021). Reduced Fatty Acid Use from CD36 Deficiency Deteriorates Streptozotocin-Induced Diabetic Cardiomyopathy in Mice. Metabolites, 11(12), 881. https://doi.org/10.3390/metabo11120881